|
⚲
|
| Keyboard |
| Sukhtian Ghiath M
✚
|
|
|---|---|
| CIK # | 0001717441 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001717441] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| GMS Ventures & Investments | |
| Sukhtian Ghiath M | |
| Outlook Therapeutics Inc | |
| BioLexis Pte Ltd | |
| Pillai Arun Kumar |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Outlook Therapeutics Inc OTLK
Warrants (right to buy) · derivative
|
2025-05-27 | Grant | 8,571,428 | ||
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2025-05-27 | Grant | 4,285,714 | $1.40 | 6,000,000 |
|
Outlook Therapeutics Inc OTLK
Warrants (right to buy) · derivative
|
2025-01-17 | Grant | 3,458,571 | ||
|
Outlook Therapeutics Inc OTLK
Warrants (right to buy) · derivative
|
2025-01-17 | Grant | 3,458,571 | ||
|
Outlook Therapeutics Inc OTLK
Warrants (right to buy) · derivative
|
2025-01-17 | Disposed to issuer | 3,458,571 | ||
|
Outlook Therapeutics Inc OTLK
Warrants (right to buy) · derivative
|
2025-01-17 | Grant | 3,458,571 | ||
|
Outlook Therapeutics Inc OTLK
Warrants (right to buy) · derivative
|
2025-01-17 | Option exercise | 3,458,571 | ||
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2024-03-18 | Grant | 2,305,714 | ||
|
Outlook Therapeutics Inc OTLK
Warrants (right to buy) · derivative
|
2024-03-18 | Grant | 3,458,571 | ||
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2022-12-28 | Grant | 14,230,418 | $0.88 | 12,522,768 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2022-02-01 | Other | 2,500,000 | $1.25 | 3,125,000 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2021-11-29 | Buy | 16,000,000 | $1.25 | 20,000,000 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2021-02-10 | Grant | 1,013,627 | $1.00 | 1,013,627 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2021-02-02 | Buy | 8,360,000 | $1.00 | 8,360,000 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2020-03-23 | Option exercise | 29,358,621 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2020-03-23 | Option exercise | 68,112 | ||
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2020-03-19 | Grant | 68,112 | ||
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2020-03-19 | Disposed to issuer | 68,112 | ||
|
Outlook Therapeutics Inc OTLK
Warrants · derivative
|
2020-02-26 | Grant | 1,230,315 | $0.13 | 159,941 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2020-02-26 | Grant | 2,460,630 | $1.02 | 2,509,843 |
| showing 20 of 54 most recent transactions | |||||